Efficacy and safety of concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced nasopharyngeal cancers

Baykara, Meltem; Buyukberber, Suleyman; Ozturk, Banu; Coskun, UĞUR; Kaplan, Muhammet; Unsal, Diclehan; Dane, Faysal; Demirci, Umut; BORA, HÜSEYİN; Benekli, Mustafa

doi:10.1700/1361.15096

Efficacy and safety of concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced nasopharyngeal cancers

Atıf İçin Kopyala

Baykara M., Buyukberber S., Ozturk B., Coskun U., Kaplan M. A., Unsal D. K., ...Daha Fazla

TUMORI, cilt.99, sa.4, ss.469-473, 2013 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 99 Sayı: 4
Basım Tarihi: 2013
Doi Numarası: 10.1700/1361.15096
Dergi Adı: TUMORI
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.469-473
Gazi Üniversitesi Adresli: Evet

Özet

Aims and background. Chemoradiation using cisplatin-based regimens has become the standard care in the treatment of nasopharyngeal cancers, The impact of taxanes as radiosensitizing agents with concurrent chemoradiation regimens is unknown. We retrospectively evaluated the efficacy and tolerability of weekly cisplatin + docetaxel combination with chemoradiation in locally advanced nasopharyngeal cancers.